Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Generics segment includes a retail and institutional portfolio of over 270 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
Símbolo de cotizaciónAMRX
Nombre de la empresaAmneal Pharmaceuticals Inc
Fecha de salida a bolsaNov 18, 2009
Director ejecutivoMr. Chintu Patel
Número de empleados8100
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 18
Dirección400 Crossing Boulevard, 3rd Floor
CiudadBRIDGEWATER
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal08807
Teléfono19089473120
Sitio Webhttps://amneal.com/
Símbolo de cotizaciónAMRX
Fecha de salida a bolsaNov 18, 2009
Director ejecutivoMr. Chintu Patel
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos